دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Practical considerations for the use of SGLT-2 inhibitors in the Asia–Pacific countries�An expert consensus statement
Adrian Liew, Aida Lydia, Bien J. Matawaran, Paweena Susantitaphong, Huong Thi Bich Tran, Lee Ling Lim
doi : 10.1111/nep.14167
Recent clinical studies have demonstrated the effectiveness of SGLT-2 inhibitors in reducing the risks of cardiovascular and renal events in both patients with and without type 2 diabetes mellitus. Consequently, many international guidelines have begun advocating for the use of SGLT-2 inhibitors for the purpose of organ protection rather than as simply a glucose-lowering agent.
Is metabolic-dysfunction-associated fatty liver disease or advanced liver fibrosis associated with erythropoietin stimulating agent hypo-responsiveness among patients with end-stage kidney disease on haemodialysis?
Wei-Kei Wong, Wah-Kheong Chan, Shubash Ganapathy, Soo-Kun Lim
doi : 10.1111/nep.14186
This study aims to determine if metabolic-dysfunction-associated fatty liver disease (MAFLD) or advanced liver fibrosis is associated with erythropoietin stimulating agent (ESA) hypo-responsiveness in hemodialysis patients.
Estimating baseline creatinine to detect acute kidney injury in patients with chronic kidney disease
Thomas Larsen, Emily J. See, Natasha E. Holmes, Rinaldo Bellomo
doi : 10.1111/nep.14191
Accurately estimating baseline kidney function is essential for diagnosing acute kidney injury (AKI) in patients with chronic kidney disease (CKD). We developed and evaluated novel equations to estimate baseline creatinine in patients with AKI on CKD.
A retrospective database analysis of erythropoiesis-stimulating agent treatment patterns and associated healthcare resource use in patients with non–dialysis-dependent chronic kidney disease–related anaemia in Japan
Sari Mishina, Miina Waratani, Satoshi Onozawa, Hiroyuki Okumura, Yuichiro Ito, Yoshinari Yasuda
doi : 10.1111/nep.14168
This study was conducted to evaluate clinical characteristics, treatment patterns, and healthcare resource use (HCRU) for patients in Japan with non–dialysis-dependent chronic kidney disease (CKD) and anaemia.
Financial toxicity experienced by rural Australian families with chronic kidney disease
Nicole Scholes-Robertson, Katrina Blazek, Allison Tong, Talia Gutman, Jonathan C. Craig, Beverley M. Essue, Kirsten Howard, Germaine Wong, Martin Howell
doi : 10.1111/nep.14192
Chronic kidney disease (CKD) and its treatment places a financial burden on healthcare systems and households worldwide, yet little is known of its financial impact, on those who reside in rural settings. We aimed to quantify the financial impacts and out-of-pocket expenditure experienced by adult rural patients with CKD in Australia.
Cecal volvulus: A rare cause of intestinal obstruction after peritoneal dialysis catheter insertion
Qinghua Yang, Jiaxiang Ding, Yankai Zhang, Ning Ning, Mei Wang
doi : 10.1111/nep.14172
Oxalate nephropathy in ataxia telangiectasia – A case report
Leonie R. Perera, Edmund Y. M. Chung, Sarah Roxburgh
doi : 10.1111/nep.14173
Utility of post-transplant native nephrectomy in children with nephropathic cystinosis: A single centre retrospective study
Ratna Acharya, Rachel Bush, Felicia Johns, Kiran Upadhyay
doi : 10.1111/nep.14189
